Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial.
Hyeong Dong YukChang Wook JeongCheol KwakHyeon KimKyung Chul MoonJa Hyeon KuPublished in: BMJ open (2020)
NCT03577132.